• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-219-5p通过靶向Twist/Wnt/β-连环蛋白信号通路抑制上皮性卵巢癌细胞的增殖、迁移和侵袭。

MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.

作者信息

Wei Chunyan, Zhang Xi, He Sai, Liu Bianli, Han Hongfang, Sun Xuejun

机构信息

Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.

Department of Neurosurgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.

出版信息

Gene. 2017 Dec 30;637:25-32. doi: 10.1016/j.gene.2017.09.012. Epub 2017 Sep 7.

DOI:10.1016/j.gene.2017.09.012
PMID:28890378
Abstract

MicroRNAs are emerging as critical regulators in various fundamental biological processes, including tumor progression. MicroRNA-219-5p (miR-219-5p) has been suggested as a novel tumor suppressing miRNA for many types of human cancers. However, the expression and functional significance of miR-219-5p in epithelial ovarian cancer remain poorly understood. In this study, we sought to explore the potential functions of miR-219-5p in epithelial ovarian cancer. Herein, we found that miR-219-5p levels were significantly decreased in epithelial ovarian cancer tissues and cell lines. Further experiments showed that overexpression of miR-219-5p inhibited epithelial ovarian cancer cell proliferation, migration, and invasion, and suppressed the Wnt/β-catenin signaling pathway. By contrast, suppression of miR-219-5p exhibited the opposite effects. Twist was identified as a downstream target of miR-219-5p, and its expression was directly regulated by miR-219-5p. Restoration of Twist expression in miR-219-5p-overexpresing cells significantly reversed the antitumor effects of miR-219-5p. Taken together, our results revealed a tumor suppressive role for miR-219-5p in epithelial ovarian cancer that includes suppression of cell proliferation, migration, and invasion through downregulation of the Twist/Wnt/β-catenin signaling pathway. Our study suggests that miR-219-5p may have potential applications in the diagnosis and treatment of epithelial ovarian cancer.

摘要

微小RNA正成为包括肿瘤进展在内的各种基本生物学过程中的关键调节因子。微小RNA - 219 - 5p(miR - 219 - 5p)已被认为是多种人类癌症的新型肿瘤抑制性微小RNA。然而,miR - 219 - 5p在上皮性卵巢癌中的表达及功能意义仍知之甚少。在本研究中,我们试图探索miR - 219 - 5p在上皮性卵巢癌中的潜在功能。在此,我们发现上皮性卵巢癌组织和细胞系中miR - 219 - 5p水平显著降低。进一步实验表明,miR - 219 - 5p的过表达抑制上皮性卵巢癌细胞的增殖、迁移和侵袭,并抑制Wnt/β - 连环蛋白信号通路。相反,抑制miR - 219 - 5p则表现出相反的效果。Twist被确定为miR - 219 - 5p的下游靶点,其表达直接受miR - 219 - 5p调控。在miR - 219 - 5p过表达细胞中恢复Twist表达可显著逆转miR - 219 - 5p的抗肿瘤作用。综上所述,我们的结果揭示了miR - 219 - 5p在上皮性卵巢癌中的肿瘤抑制作用,包括通过下调Twist/Wnt/β - 连环蛋白信号通路来抑制细胞增殖、迁移和侵袭。我们的研究表明,miR - 219 - 5p可能在上皮性卵巢癌的诊断和治疗中具有潜在应用价值。

相似文献

1
MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.微小RNA-219-5p通过靶向Twist/Wnt/β-连环蛋白信号通路抑制上皮性卵巢癌细胞的增殖、迁移和侵袭。
Gene. 2017 Dec 30;637:25-32. doi: 10.1016/j.gene.2017.09.012. Epub 2017 Sep 7.
2
lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.lncRNA JPX/miR-33a-5p/Twist1 轴通过激活 Wnt/β-catenin 信号通路调节肺癌的发生和转移。
Mol Cancer. 2020 Jan 15;19(1):9. doi: 10.1186/s12943-020-1133-9.
3
LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.长链非编码 RNA HOXD-AS1 通过靶向 miR-133a-3p 并激活 Wnt/β-catenin 信号通路促进卵巢癌细胞的增殖和侵袭。
Biomed Pharmacother. 2017 Dec;96:1216-1221. doi: 10.1016/j.biopha.2017.11.096. Epub 2017 Nov 26.
4
MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.微小RNA-361-5p通过靶向Twist1抑制胶质瘤细胞的上皮-间质转化
Oncol Rep. 2017 Mar;37(3):1849-1856. doi: 10.3892/or.2017.5406. Epub 2017 Jan 25.
5
Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.下调 microRNA-31-5p 通过增强 AXIN1 抑制骨肉瘤细胞的增殖和侵袭,通过 Wnt/β-catenin 信号通路。
Exp Mol Pathol. 2019 Jun;108:32-41. doi: 10.1016/j.yexmp.2019.03.001. Epub 2019 Mar 4.
6
SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.SOX30 是 miR-653-5p 的靶基因,通过抑制 Wnt/β-catenin 信号通路抑制前列腺癌细胞的增殖和侵袭。
Cell Mol Biol Lett. 2019 Dec 23;24:71. doi: 10.1186/s11658-019-0195-4. eCollection 2019.
7
MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.微小RNA-219-5p通过靶向肝受体同源物-1/ Wnt/β-连环蛋白信号通路抑制胃癌细胞的增殖、迁移和侵袭。
Oncol Res. 2017 Apr 14;25(4):617-627. doi: 10.3727/096504016X14768374457986. Epub 2016 Oct 27.
8
MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.微小RNA-548c通过下调Twist蛋白来损害子宫内膜癌细胞和卵巢癌细胞的迁移与侵袭能力。
J Exp Clin Cancer Res. 2016 Jan 13;35:10. doi: 10.1186/s13046-016-0288-0.
9
MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.微小 RNA-449b-5p 通过抑制 CREPT 介导的 Wnt/β-连环蛋白信号通路抑制乳腺癌细胞的生长和侵袭。
Chem Biol Interact. 2019 Apr 1;302:74-82. doi: 10.1016/j.cbi.2019.02.004. Epub 2019 Feb 7.
10
MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.miR-206 通过阻断 c-Met/AKT/mTOR 信号通路抑制上皮性卵巢癌细胞的生长和侵袭。
Biomed Pharmacother. 2018 Aug;104:763-770. doi: 10.1016/j.biopha.2018.05.077. Epub 2018 May 29.

引用本文的文献

1
Long Non-Coding, Micro, and Circular RNAs in Ovarian Cancer Metastasis: Pathways and Treatment Approaches.长链非编码RNA、微小RNA和环状RNA在卵巢癌转移中的作用:途径与治疗方法
Reprod Sci. 2025 Aug 15. doi: 10.1007/s43032-025-01948-x.
2
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
3
Hypermethylation and suppression of microRNA219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis.
微小RNA219a-2的高甲基化和抑制激活了醛脱氢酶1L2/谷胱甘肽/纤溶酶原激活物抑制因子-1途径,导致肾纤维化中纤连蛋白降解。
Mol Ther. 2025 Jan 8;33(1):249-262. doi: 10.1016/j.ymthe.2024.09.020. Epub 2024 Sep 17.
4
Prognostic value of miR-219-5p in relation to mortality in patients with small cell lung cancer: a retrospective, observational cohort study in China.miR-219-5p 对小细胞肺癌患者死亡率的预后价值:中国的一项回顾性观察队列研究。
BMJ Open. 2023 Mar 30;13(3):e064700. doi: 10.1136/bmjopen-2022-064700.
5
Propofol-Induced miR-493-3p Inhibits Growth and Invasion of Gastric Cancer through Suppression of DKK1-Mediated Wnt/-Catenin Signaling Activation.异丙酚诱导的 miR-493-3p 通过抑制 DKK1 介导的 Wnt/-Catenin 信号激活抑制胃癌的生长和侵袭。
Dis Markers. 2023 Jan 31;2023:7698706. doi: 10.1155/2023/7698706. eCollection 2023.
6
Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway.大麻植物源类大麻素成分与 PARP1 抑制剂协同作用,在体外抗卵巢癌细胞,并影响 Wnt 信号通路。
Molecules. 2022 Nov 3;27(21):7523. doi: 10.3390/molecules27217523.
7
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.全面综述微小 RNA 在卵巢癌化疗耐药中的作用;最新综述。
J Ovarian Res. 2022 Jul 7;15(1):81. doi: 10.1186/s13048-022-01012-1.
8
Plasma miRNA Profile of Crohn's Disease and Rheumatoid Arthritis Patients.克罗恩病和类风湿关节炎患者的血浆微小RNA谱
Biology (Basel). 2022 Mar 25;11(4):508. doi: 10.3390/biology11040508.
9
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.卵巢癌中的癌症干细胞——肿瘤成功的根源和新型治疗的挑战性靶点。
Int J Mol Sci. 2022 Feb 24;23(5):2496. doi: 10.3390/ijms23052496.
10
Ovarian cancer: epigenetics, drug resistance, and progression.卵巢癌:表观遗传学、耐药性与进展
Cancer Cell Int. 2021 Aug 17;21(1):434. doi: 10.1186/s12935-021-02136-y.